Cardiomyopathy is a leading cause of heart failure in children, and there are currently no effective treatments. Could emerging therapies that successfully target the root cause of the condition in adults also work well in children? That was the question Dr....
In the realm of cardiac health, an exciting new study has cast light on the intricate details of our hearts, revealing significant differences between the left and right ventricles' fibroblasts. This research, conducted by a team of dedicated scientists from the...
For children diagnosed with complex heart conditions like hypertrophic cardiomyopathy (HCM), the diagnosis can be frightening for families and challenging for healthcare providers since the trajectory of the condition is often uncertain. As a leading cause of sudden...
An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
Several members of the Ted Rogers Centre for Heart Research (TRCHR) participated in Vascular 2023, a five-day conference held in Montreal from October 25-29. The conference is a hallmark event organized by several Canadian specialist and research organizations,...
Researchers at the Ted Rogers Centre for Heart Research have developed an innovative approach to better understanding the complex signaling mechanisms underlying heart failure. A recent publication in the Proceedings of the National Academy of Sciences (PNAS) offers...
The Ted Rogers Centre for Heart Research launched in 2014 after what was the largest private gift in Canadian health-care history united three world-renowned institutions: The Hospital for Sick Children, University Health Network and the University of Toronto.
Six years after visionary entrepreneur Ted Rogers died of heart failure, the Rogers family made a $130 million donation to pioneer a collaborative effort to study that same disease. It was matched by each partner, creating an unprecedented $270 million commitment to positively impact one of the most challenging chronic diseases in the world.
“Our children and I wanted to do something very meaningful in Ted’s memory,” said Loretta Rogers at the Centre’s launch in November 2014.
Heart failure took Ted from us when he was 75 years old. In the future, we want fewer Canadians to experience heart failure and allow those who do to live much longer.
At the heart of our story is “the promise of a healthy heart.” For it, we are building an person-centred approach to heart failure care and prevention – no longer a lofty ambition but instead an achievable necessity.